Humoral Immunity

The term humoral refers to the non-cellular components of the blood, such as plasma and lymphatic fluid. The humoral immune response denotes immunologic responses that are mediated by antibodies.

Humoral Immunity
Humoral Immunity.ppt

Humoral Immunity Antibodies
Humoral Immunity Antibodies.ppt

Humoral Immune Response
Terry Kotrla, MS, MT(ASCP)BB
HumoralImmuneResponse.ppt
HumoralImmuneResponseFall2010.ppt

Effector Mechanisms of Humoral Immunity
Effector Mechanisms of Humoral Immunity.ppt

Immunity mediated by B-lymphocytes and Antibodies
Immunity mediated by B-lymphocytes and Antibodies.ppt

The Immune System: Innate and Adaptive Body Defenses
The Immune System.ppt

The Immune system
The Immune System.ppt

Adaptive/Acquired Immunity
Adaptive_Immunity2.ppt

Specific Host Defenses: The Immune Response
SpecificDefenses.ppt

The Body’s Defenses
Immunity.ppt

Acquired – Specific – Adaptive Immunity
Acquired – Specific – Adaptive Immunity.ppt

Immunity Body Defenses
ImmunityF07.ppt

Immune System
Daryl Beatty
Immune System.ppt

DNA Vaccines
DNA Vaccines.ppt

Adaptive Immunity: Specific Defenses of the Host
Adaptive Immunity.ppt

Immunity and Cell Defense
Lukasz Stelinski
Immunity and Cell Defense.ppt

Humoral Immune Response
Humoral Immune Response.ppt

Adaptive Immune Response
Adaptive Immune Response.ppt

The Immune System
immune.ppt

Immunity and Autoimmune Disease
Jessica Rando
Immunologyfinal.ppt

Immune Response and Immunity
Mark D. Sobsey
Immune Response and Immunity.ppt

Humoral Immunity: B Cells
SpecificResistII.ppt

Immunity – The War Against Infection
Immunity – The War Against Infection.ppt

Lymphatics and the Immune System
Lymphatics and the Immune System.ppt
Published articles on humoral immunity Free access

1. PLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity.
2. Enhancement of humoral immunity in mice by coupling pUCpGs10 and aluminium to the HCV recombinant immunogen.
3. Study on the role of humoral immunity in renal transplant rejections and its correlation with histopathological findings.
4. Prediction of steroid response in nephrotic syndrome by humoral immunity assessment.
5. Blockade of B7-H1 (programmed death ligand 1) enhances humoral immunity by positively regulating the generation of T follicular helper cells.
6. Serologic imprint of dengue virus in urban Haiti: characterization of humoral immunity to dengue in infants and young children.
7. Mutation of putative N-linked glycosylation sites in Japanese encephalitis virus premembrane and envelope proteins enhances humoral immunity in BALB/C mice after DNA vaccination.
8. Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus.
9. Targeting of whole killed bacteria to gastrointestinal M-cells induces humoral immunity in the female reproductive tract.
10. TCDD adsorbed on silica as a model for TCDD contaminated soils: Evidence for suppression of humoral immunity in mice.
11. Arachidonate 5-lipoxygenase establishes adaptive humoral immunity by controlling primary B cells and their cognate T-cell help.
12. Preexisting vaccinia virus immunity decreases SIV-specific cellular immunity but does not diminish humoral immunity and efficacy of a DNA/MVA vaccine.
13. TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin.
14. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
15. Induction of both cellular and humoral immunity following a rational prime-boost immunization regimen that incorporates recombinant ovine atadenovirus and fowlpox virus.
16. Alleviation of cyclic heat stress in broilers by dietary supplementation of mannan-oligosaccharide and Lactobacillus-based probiotic: dynamics of cortisol, thyroid hormones, cholesterol, C-reactive protein, and humoral immunity.
17. Metastatic melanomas express inhibitory low affinity fc gamma receptor and escape humoral immunity.
18. Relationship of Pneumocystis jiroveci humoral immunity to prevention of colonization and chronic obstructive pulmonary disease in a primate model of HIV infection.
19. Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice.
20. Toll-like receptor agonists allow generation of long-lasting antipneumococcal humoral immunity in response to a plain polysaccharidic vaccine.
21. Role of humoral immunity in host defense against HIV.
22. Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adults.
23. Dendritic cells and humoral immunity in humans.
24. A detrimental effect of interleukin-10 on protective pulmonary humoral immunity during primary influenza A virus infection.
25. Differential impact of ageing on cellular and humoral immunity to a persistent murine gamma-herpesvirus.
26. Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression.
27. Innate and adaptive receptors interact to balance humoral immunity.
28. Rapid escape from preserved cross-reactive neutralizing humoral immunity without loss of viral fitness in HIV-1-infected progressors and long-term nonprogressors.
29. Humoral immunity in tuberculin skin test anergy and its role in high-risk persons exposed to active tuberculosis.
30. Humoral immunity to human metapneumovirus infection in adults.
31. Adjuvantive effects of anti-4-1BB agonist Ab and 4-1BBL DNA for a HIV-1 Gag DNA vaccine: different effects on cellular and humoral immunity.
32. Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.
33. [Efficacy and regulation of humoral immunity of jade screen powder as an adjunct therapy in children with asthma].
34. Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection.
35. Humoral immunity to West Nile virus is long-lasting and protective in the house sparrow (Passer domesticus).
36. IL-12 as an adjuvant for the enhancement of protective humoral immunity.
37. CD98hc facilitates B cell proliferation and adaptive humoral immunity.
38. Suppression of humoral immunity by perfluorooctanoic acid is independent of elevated serum corticosterone concentration in mice.
39. A novel ICOS-independent, but CD28- and SAP-dependent, pathway of T cell-dependent, polysaccharide-specific humoral immunity in response to intact Streptococcus pneumoniae versus pneumococcal conjugate vaccine.
40. Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis.
41. Humoral immunity against capsule polysaccharide protects the host from magA+ Klebsiella pneumoniae-induced lethal disease by evading Toll-like receptor 4 signaling.
42. Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction.
43. BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact.
44. Systemic humoral immunity to non-typeable Haemophilus influenzae.
45. Net positive charge of HIV-1 CRF01_AE V3 sequence regulates viral sensitivity to humoral immunity.
46. Associations between cytokine/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population.
47. Alterations in humoral immunity in relatives of patients with common variable immunodeficiency.
48. Rap1b regulates B cell development, homing, and T cell-dependent humoral immunity.
49. Influenza virus vaccination induces interleukin-12/23 receptor beta 1 (IL-12/23R beta 1)-independent production of gamma interferon (IFN-gamma) and humoral immunity in patients with genetic deficiencies in IL-12/23R beta 1 or IFN-gamma receptor I.
50. Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection.
51. Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate.
52. Recovery of humoral immunity is critical for successful antiviral therapy in disseminated mouse adenovirus type 1 infection.
53. SAP expression in T cells, not in B cells, is required for humoral immunity.
54. Alteration of cellular and humoral immunity by mutant p53 protein and processed mutant peptide in head and neck cancer.
55. B cell intrinsic TLR signals amplify but are not required for humoral immunity.
56. Duration of humoral immunity to common viral and vaccine antigens.
57. Initiation of protein O glycosylation by the polypeptide GalNAcT-1 in vascular biology and humoral immunity.
58. Quantitative mouse model of implant-associated osteomyelitis and the kinetics of microbial growth, osteolysis, and humoral immunity.
59. T-Cell-independent humoral immunity is sufficient for protection against fatal intracellular ehrlichia infection.
60. Effects of source of supplemental zinc on performance and humoral immunity in beef heifers.
61. MyD88 is required for the formation of long-term humoral immunity to virus infection.
62. Neuronal and myelin reactive humoral immunity in multiple sclerosis is Th2 dependent.
63. Subunit vaccines based on intimin and Efa-1 polypeptides induce humoral immunity in cattle but do not protect against intestinal colonisation by enterohaemorrhagic Escherichia coli O157:H7 or O26:H-.
64. Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease.
65. SAP regulation of follicular helper CD4 T cell development and humoral immunity is independent of SLAM and Fyn kinase.
66. Corticosterone selectively decreases humoral immunity in female eiders during incubation.
67. Carcinogen-modified DNA and specific humoral immunity toward carcinogen-DNA adducts. A review.
68. Vaccination with viable human umbilical vein endothelial cells prevents metastatic tumors by attack on tumor vasculature with both cellular and humoral immunity.
69. Transgenerational priming of immunity: maternal exposure to a bacterial antigen enhances offspring humoral immunity.
70. Fiber and penton base capsid modifications yield diminished adenovirus type 5 transduction and proinflammatory gene expression with retention of antigen-specific humoral immunity.
71. Transcription factors TFE3 and TFEB are critical for CD40 ligand expression and thymus-dependent humoral immunity.
72. Constitutive expression of outer surface protein C diminishes the ability of Borrelia burgdorferi to evade specific humoral immunity.
73. A dose-dependent requirement for the proline motif of CD28 in cellular and humoral immunity revealed by a targeted knockin mutant.
74. NQO1 and NQO2 regulation of humoral immunity and autoimmunity.
75. Subtly impaired humoral immunity predisposes to frequently recurring genital herpes simplex virus type 2 infection and herpetic neuralgia.
76. Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients.
77. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner.
78. Evidence for a novel endocrine disruptor: the pesticide propanil requires the ovaries and steroid synthesis to enhance humoral immunity.
79. Deciphering CD30 ligand biology and its role in humoral immunity.
80. SAP regulates T cell-mediated help for humoral immunity by a mechanism distinct from cytokine regulation.
81. [PLAC1/CP1 gene expression and autologous humoral immunity in gastric cancer patients].
82. Dissociation of lung function changes with humoral immunity during inhaled human insulin therapy.
83. Characterization of preexisting humoral immunity specific for two cancer-testis antigens overexpressed at the mRNA level in non-small cell lung cancer.
84. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity.
85. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement.
86. Essential role for humoral immunity during Ehrlichia infection in immunocompetent mice.
87. A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
88. Human male genital tract secretions: both mucosal and systemic immune compartments contribute to the humoral immunity.
89. The CD9 tetraspanin is not required for the development of peripheral B cells or for humoral immunity.
90. characterization of acute-phase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak.
91. Comprehensive antibody epitope mapping of the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus: insight into the humoral immunity of SARS.
92. Effects of probiotic bacteria on humoral immunity to Candida albicans in immunodeficient bg/bg-nu/nu and bg/bg-nu/+ mice.
93. Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells.
94. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
95. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
96. Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys.
97. Cellular and humoral immunity following Snow Mountain virus challenge.
98. Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity.
99. Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on toll-like receptor 2.
100. The role of CXCR4 in maintaining peripheral B cell compartments and humoral immunity.
101. Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer.
102. Humoral immunity through immunoglobulin M protects mice from an experimental actinomycetoma infection by Nocardia brasiliensis.
103. Protective niche for Borrelia burgdorferi to evade humoral immunity.
104. FTY720 suppresses humoral immunity by inhibiting germinal center reaction.
105. A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice.
106. Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine.
107. Limited contribution of humoral immunity to the clearance of measles viremia in rhesus monkeys.
108. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
109. Ageing, autoimmunity and arthritis: senescence of the B cell compartment - implications for humoral immunity.
110. Incomplete humoral immunity against hepatitis C virus is linked with distinct recognition of putative multiple receptors by E2 envelope glycoprotein.
111. Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point.
112. Interleukin-21 is a T-helper cytokine that regulates humoral immunity and cell-mediated anti-tumour responses.
113. Study of humoral immunity to commensal oral bacteria in human infants demonstrates the presence of secretory immunoglobulin A antibodies reactive with Actinomyces naeslundii genospecies 1 and 2 ribotypes.
114. Cellular and humoral immunity against vaccinia virus infection of mice.
115. Our current understanding of humoral immunity of poultry.
116. Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children.
117. A nonproliferating parvovirus vaccine vector elicits sustained, protective humoral immunity following a single intravenous or intranasal inoculation.
118. Humoral immunity to Ro52 is not associated with the Ro52 9571 C/T polymorphism in Australian patients with primary Sjögren's syndrome.
119. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection.
120. Humoral immunity against Bordetella pertussis: antibodies or B cells?
121. Opposing signals from pathogen-associated molecular patterns and IL-10 are critical for optimal dendritic cell induction of in vivo humoral immunity to Streptococcus pneumoniae.
122. Flexible migration program regulates gamma delta T-cell involvement in humoral immunity.
123. The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease.
124. Reductions in total body fat decrease humoral immunity.
125. Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression.
126. Humoral immunity reflects altered T helper cell bias in Borrelia burgdorferi-infected gamma delta T-cell-deficient mice.
127. Epitope-specific humoral immunity to Plasmodium vivax Duffy binding protein.
128. IL-4-producing CD8+ T cells with a CD62L++(bright) phenotype accumulate in a subgroup of older adults and are associated with the maintenance of intact humoral immunity in old age.
129. Macrophage-derived complement component C4 can restore humoral immunity in C4-deficient mice.
130. Humoral immunity and bronchiectasis.
131. CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice.
132. Capillary C4d deposition as a marker of humoral immunity in renal allograft rejection.
133. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection.
134. Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo.
135. Cellular and humoral immunity to purified protein derivative (PPD) in PPD skin reactive and nonreactive patients with pulmonary tuberculosis: comparative analysis of antigen-specific lymphocyte proliferation and IgG antibodies.
136. Short-circuiting long-lived humoral immunity by the heightened engagement of CD40.
137. CD28(-/-) mice show defects in cellular and humoral immunity but are able to control infection with murine gammaherpesvirus 68.
138. Contribution of humoral immunity to the therapeutic response in falciparum malaria.
139. Engagement of OX40 enhances antigen-specific CD4(+) T cell mobilization/memory development and humoral immunity: comparison of alphaOX-40 with alphaCTLA-4.
140. Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.
141. Antigen-pulsed dendritic cells expressing macrophage-derived chemokine elicit Th2 responses and promote specific humoral immunity.
142. Slow recovery of follicular B cells and marginal zone B cells after chemotherapy: implications for humoral immunity.
143. Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development.
144. Tumours can act as adjuvants for humoral immunity.
145. Cell-mediated and humoral immunity and phagocytic ability in chicken Lines divergently selected for serum immunoglobulin M and G levels.
146. Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0-6 months.
147. Instillation of allogeneic lung antigen-presenting cells deficient in expression of major histocompatibility complex class I or II antigens have differential effects on local cellular and humoral immunity and on pathology in recipient murine lungs.
148. The senescence-accelerated mouse shows aging-related defects in cellular but not humoral immunity against influenza virus infection.
149. Effect of cellular changes and onset of humoral immunity on the replication of porcine reproductive and respiratory syndrome virus in the lungs of pigs.
150. Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle.
151. Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy.
152. Complement fixation test to assess humoral immunity in cattle and sheep vaccinated with Brucella abortus RB51.
153. Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo.
154. Humoral immunity to commensal oral bacteria in human infants: salivary secretory immunoglobulin A antibodies reactive with Streptococcus mitis biovar 1, Streptococcus oralis, Streptococcus mutans, and Enterococcus faecalis during the first two years of life.
155. Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity.
156. The memory B cell subset responsible for the secretory IgA response and protective humoral immunity to rotavirus expresses the intestinal homing receptor, alpha4beta7.
157. Age-related buildup of humoral immunity against epitopes for rosette formation and agglutination in African areas of malaria endemicity.
158. Humoral immunity to commensal oral bacteria in human infants: salivary antibodies reactive with Actinomyces naeslundii genospecies 1 and 2 during colonization.
159. Evaluation of the Galalpha1-3Gal epitope as a host modification factor eliciting natural humoral immunity to enveloped viruses.
160. Humoral immunity to Borrelia burgdorferi N40 decorin binding proteins during infection of laboratory mice.
161. Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein.
162. Mice carrying a truncated Apc gene have diminished gastric epithelial proliferation, gastric inflammation, and humoral immunity in response to Helicobacter felis infection.
163. Summary of antibody workshop: The Role of Humoral Immunity in the Treatment and Prevention of Emerging and Extant Infectious Diseases.
164. Immunoprecipitation of steroidogenic enzyme autoantigens with autoimmune polyglandular syndrome type I (APS I) sera; further evidence for independent humoral immunity to P450c17 and P450c21.
165. Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.
166. Intimal thickening develops without humoral immunity in a mouse aortic allograft model of chronic vascular rejection.
167. Recipient humoral immunity against leukoreduced allogeneic platelets is suppressed by aminoguanidine, a selective inhibitor of inducible nitric oxide synthase.
168. Induction of humoral immunity toward 2-acetylaminofluorene in mice: modulation of DNA binding after 4 weeks dietary exposure to the carcinogen.
169. An orally supplemented mononucleotide mixture prevents the decrease in T cell-dependent humoral immunity in C57BL/6 mice fed a nucleotide-free diet.
170. Silicate antibodies in women with silicone breast implants: development of an assay for detection of humoral immunity.
171. Selective suppression of in vitro T-dependent humoral immunity by synthetic food additive antioxidants.
172. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression.
173. Humoral immunity to aerosolized staphylococcal enterotoxin B (SEB), a superantigen, in monkeys vaccinated with SEB toxoid-containing microspheres.
174. In vitro evaluation of the role of humoral immunity against Bartonella henselae.
175. Assessing mucosal humoral immunity.
176. Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor.
177. Brief report: enhanced humoral immunity in common variable immunodeficiency after long-term treatment with polyethylene glycol-conjugated interleukin-2.
178. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.
179. Effect of fresh frozen plasma and gammaglobulin on humoral immunity in neonatal sepsis.
180. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.
181. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions.
182. Modulation of cellular and humoral immunity, and disease manifestation during onset of patency in Brugia pahangi-infected dogs.
183. Direct evidence that primary acquired cell-mediated immunity is less resistant than is primary thymus-dependent humoral immunity to the depressive influence of wasting protein-energy malnutrition in weanling mice.
184. Evidence for transfer of cellular and humoral immunity to cytomegalovirus from donor to recipient in allogeneic bone marrow transplantation.
185. Humoral immunity of older adults with periodontal disease to Porphyromonas gingivalis.
186. Smoking, humoral immunity, and ulcerative colitis.
187. Appraisal of gut lavage in the study of intestinal humoral immunity.
188. Vitamin A deficiency: serum cortisol and humoral immunity in lambs.
189. Lymphoid cell transfers between adult C57BL/6 mice differing at the lpr and/or nu locus. Humoral immunity phenotype of the chimeras.
190. [Relationship between the effects of praziquantel on mice and rabbits with different intensities of Schistosoma japonicum infection and humoral immunity levels of the host].
191. Humoral immunity in mice mediated by monoclonal antibodies against the A and M antigens of Brucella.
192. The immunological consequences of feeding cholera toxin. I. Feeding cholera toxin suppresses the induction of systemic delayed-type hypersensitivity but not humoral immunity.
193. Humoral immunity to link protein in patients with inflammatory joint disease, osteoarthritis, and in non-arthritic controls.
194. The complementary roles of cellular and humoral immunity in resistance to re-infection with LCM virus.
195. Effect of heptaminol AMP amidate, a new nucleotide derivative, on in vitro humoral immunity.
196. Humoral immunity in aged mice exposed to cadmium.
197. Immunization of salmonids against Yersinia ruckeri: significance of humoral immunity and cross protection between serotypes.
198. Suppression of humoral immunity in dogs by 15-deoxyspergualin.
199. Evidence for depressed humoral immunity to Pneumocystis carinii in homosexual males, commercial plasma donors, and patients with acquired immunodeficiency syndrome.
200. Abnormal cellular and humoral immunity in childhood acute lymphoblastic leukemia in long-term remission.
201. Comparison of cell-mediated and humoral immunity in the dog lung after localized lung immunization.
202. Humoral immunity against Francisella tularensis after natural infection.
203. Detection of cellular and humoral immunity to hepatitis B surface antigen (HBsAg) in asymptomatic HBsAg carriers.
204. Effect of specific humoral immunity and some non-specific factors on resistance of volunteers to respiratory coronavirus infection.
205. Humoral immunity against viral antigens in insulin-dependent diabetes mellitus (IDDM): altered IgA class immune response against mumps virus.
206. Potentiation of human cell-mediated and humoral immunity by low-dose cyclophosphamide.
207. In vivo and in vitro humoral immunity in surgical patients.
208. Humoral immunity in chicks experiencing marginal vitamin B-6 deficiency.
209. Results of a two-year study of humoral immunity to influenza A and B viruses in children under the age of 14 years in Moscow and its suburbs.
210. Humoral immunity in essential fatty acid-deficient rats and mice: effect of route of injection of antigen.
211. Humoral immunity in cardiomyopathy.
212. Immunoprecipitation as a tool for studying humoral immunity of natural and experimental hosts of Herpesvirus saimiri.
213. Essential fatty acid deficiency, prostaglandin synthesis and humoral immunity in Lewis rats.
214. Induction of humoral immunity and pulmonary mast cells in mice and rats after immunization with aerosolized antigen.
215. The influence of ethionine-supplemented soy protein diet on cell-mediated and humoral immunity.
216. [Effect of a milk diet on parasitemia suppression and on the development of humoral immunity during the course of malarial infection in mice].
217. Induction of interleukin 1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors.
218. Protection against pulmonary blastomycosis: correlation with cellular and humoral immunity in mice after subcutaneous nonlethal infection.
219. Pathogenesis of herpes simplex virus in B cell-suppressed mice: the relative roles of cell-mediated and humoral immunity.
220. Cell-mediated and humoral immunity induced by a live Francisella tularensis vaccine.
221. Humoral immunity in leprosy: immunoglobulin G and M antibody responses to Mycobacterium leprae in relation to various disease patterns.
222. Pathogenesis of herpes simplex virus in congenitally athymic mice: the relative roles of cell-mediated and humoral immunity.
223. Studies of cellular and humoral immunity in typhoid fever and TAB vaccinated subjects.
224. Heterozygosity at Gm loci associated with humoral immunity to osteosarcoma.
225. In vitro assessment of humoral immunity following exposure to heavy metals.
226. Humoral immunity and reduced periodontal bone loss in Eikenella corrodens-monoassociated rats.
227. Cellular and humoral immunity in subacute sclerosing panencephalitis.
228. Theileriosis: cell-mediated and humoral immunity.
229. Cell-mediated and humoral immunity to herpesviruses during and after herpes zoster infections.
230. Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma.
231. Studies in chronic lymphocytic leukaemia II. Lymphocyte markers, cellular and humoral immunity and the effect of treatment.
232. Immunogenicity of the ribosomal fraction of Salmonella typhimurium: analysis of humoral immunity.
233. In vivo effect of levamisole on cellular and humoral immunity in normal chickens.
234. Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis.
235. Effects of essential fatty acid deficiency, and various levels of dietary polyunsaturated fatty acids, on humoral immunity in mice.
236. Mechanisms of trypanosome-mediated suppression of humoral immunity in mice.
237. The effects of thiol moiety of levamisole on both cellular and humoral immunity during the early response to a hapten-carrier complex.
238. Cellular and humoral immunity in guinea pigs to two major polypeptides derived from hepatitis B surface antigen.
239. Demonstration of cellular and humoral immunity to transplantable carcinomas derived from the respiratory tract of rats.
240. Cell-mediated and humoral immunity to chick type II collagen and its cyanogen bromide peptides in guinea-pigs.
241. Assessment of cellular and humoral immunity of myasthenics.
242. Appearance of cellular and humoral immunity in guinea pigs after infection with Coxiella burnetii administered in small-particle aerosols.
243. Immunological studies of patients with asbestosis. II, Studies of circulating lymphoid cell numbers and humoral immunity.
244. Humoral immunity in vaginal candidiasis.
245. The immune response in cirrhotic rats. Antigen distribution, humoral immunity, cell-mediated immunity and splenic suppressor cell activity.
246. The effects of BCG on both cellular and humoral immunity during the early response to a hapten carrier complex.
247. Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.
248. Correlations between humoral immunity and successful chemotherapy-immunotherapy.
249. Humoral immunity to Streptococcus pneumoniae induced by a pneumococcal ribosomal protein fraction.
250. The role of humoral immunity in host defence against influenza A infection in mice.
251. Cytomegalovirus infection and immunity in renal allograft recipients: assessment of the competence of humoral immunity.
252. The passive transfer of humoral immunity from sows infected with Hyostrongylus rubidus (Hassal and Stiles, 1892), the red stomach worm, to their offspring and its significance in the conferring of protective immunity.
253. Proceedings: Humoral immunity in human lung neoplasms.
254. The role of humoral immunity and acute inflammation in protection against staphyloccocal dermonecrosis.
255. Humoral immunity to a metabolite of halothane, fluroxene, and enflurane.
256. Cellular and humoral immunity to hepatitis-B surface antigen in active chronic hepatitis.
257. Naturally occurring cellular and humoral immunity to teichoic acid in rats.
258. Further studies on the effect of a transplanted methylcholanthrene-induced fibrosarcoma on humoral immunity in CBA mice.
259. Cytomegalovirus-induced immune suppression. I. Humoral immunity.
260. Some aspects of humoral immunity in germ-free and conventional SJL-J mice in relation to age and pathology.
261. Humoral immunity in juvenille rheumatoid arthritis.
262. Development of cellular and humoral immunity in the respiratory tract of rabbits to Pseudomonas lipopolysaccharide.
263. Ontogeny of bursal function in chicken. 3. Immunocompletent cell for humoral immunity.
264. The development of specific cellular and humoral immunity in mice infected with Rauscher leukemia virus as neonates or adults.
265. Relative importance of cellular and humoral immunity in human renal transplantation.
266. Prolonged administration of antithymocyte serum in mice. I. Observations on cellular and humoral immunity.
267. The development of serum proteins and humoral immunity in opossum "embryos".
268. Demonstration of cell-bound and humoral immunity against neuroblastoma cells.
269. The effect of measles infection and of vaccination with certain live vaccines upon humoral immunity to smallpox.
270. Humoral immunity in congenital rubella.
271. Two types of immunity in experimental typhoid; "cellular immunity" and "humoral immunity".
272. Changes in the titer of antipneumococcal humoral immunity in adult human beings.
273. Changes in humoral immunity occurring during the early stages of experimental pneumococcus infection.